- Home
- ALSN vs RYTM Comparison
ALSN vs RYTM Comparison
Compare ALSN & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALSN
- RYTM
- Stock Information
- Founded
- ALSN 1915
- RYTM 2008
- Country
- ALSN United States
- RYTM United States
- Employees
- ALSN N/A
- RYTM N/A
- Industry
- ALSN Auto Parts:O.E.M.
- RYTM Biotechnology: Pharmaceutical Preparations
- Sector
- ALSN Consumer Discretionary
- RYTM Health Care
- Exchange
- ALSN Nasdaq
- RYTM Nasdaq
- Market Cap
- ALSN 7.8B
- RYTM 6.9B
- IPO Year
- ALSN 2012
- RYTM 2017
- Fundamental
- Price
- ALSN $88.40
- RYTM $96.22
- Analyst Decision
- ALSN Hold
- RYTM Strong Buy
- Analyst Count
- ALSN 8
- RYTM 13
- Target Price
- ALSN $98.38
- RYTM $101.92
- AVG Volume (30 Days)
- ALSN 866.0K
- RYTM 556.3K
- Earning Date
- ALSN 10-28-2025
- RYTM 11-04-2025
- Dividend Yield
- ALSN 1.22%
- RYTM N/A
- EPS Growth
- ALSN 13.81
- RYTM N/A
- EPS
- ALSN 8.76
- RYTM N/A
- Revenue
- ALSN $3,200,000,000.00
- RYTM $156,287,000.00
- Revenue This Year
- ALSN N/A
- RYTM $44.69
- Revenue Next Year
- ALSN $2.64
- RYTM $63.53
- P/E Ratio
- ALSN $10.09
- RYTM N/A
- Revenue Growth
- ALSN 2.70
- RYTM 53.55
- 52 Week Low
- ALSN $80.39
- RYTM $45.91
- 52 Week High
- ALSN $122.53
- RYTM $106.52
- Technical
- Relative Strength Index (RSI)
- ALSN 48.12
- RYTM 47.02
- Support Level
- ALSN $88.11
- RYTM $97.47
- Resistance Level
- ALSN $91.27
- RYTM $102.46
- Average True Range (ATR)
- ALSN 1.80
- RYTM 3.33
- MACD
- ALSN 0.20
- RYTM -1.33
- Stochastic Oscillator
- ALSN 54.23
- RYTM 0.68
About ALSN Allison Transmission Holdings Inc.
Allison Transmission is the largest manufacturer of fully automatic transmissions for commercial vehicles. The company's automatic transmissions allow customers to achieve better fuel and operator efficiency than less expensive manual and automated manual transmissions. Allison serves several end markets, including on- and off-highway equipment and military vehicles. Its on-highway business has about 60% global market share. The company's transmissions can be found in Class 4-8 trucks, buses, and a limited number of large passenger vehicles (heavy-duty pickup trucks and motor homes). Allison also produces electric hybrid propulsion systems and is developing e-powertrains.
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.